{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:54:11Z","timestamp":1791478451962,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T00:00:00Z","timestamp":1502323200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s11864-017-0496-7","type":"journal-article","created":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T22:02:24Z","timestamp":1502316144000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Recent Advances in the Classification and Treatment of Ependymomas"],"prefix":"10.1007","volume":"18","author":[{"given":"Heather","family":"Leeper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"Felicella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Walbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,10]]},"reference":[{"issue":"Suppl 1","key":"496_CR1","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1093\/neuonc\/nov297","volume":"18","author":"QT Ostrom","year":"2016","unstructured":"Ostrom QT, Gittleman H, de Blank PM, Finlay JL, Gurney JG, McKean-Cowdin R, et al. American Brain Tumor Association adolescent and young adult primary brain and central nervous system tumors diagnosed in the United States in 2008-2012. Neuro-Oncology. 2016;18(Suppl 1):i1\u2013i50. doi: 10.1093\/neuonc\/nov297 .","journal-title":"Neuro-Oncology"},{"issue":"5","key":"496_CR2","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ccell.2015.04.002","volume":"27","author":"KW Pajtler","year":"2015","unstructured":"\u2022\u2022 Pajtler KW, Witt H, Sill M, Jones DT, Hovestadt V, Kratochwil F, et al. Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell. 2015;27(5):728\u201343. doi: 10.1016\/j.ccell.2015.04.002 . Basic science research utilizing DNA methylation profiles to group ependymal tumors by their similar epigenetic characteristics, identifying 9 molecular subgroups across age groups, locations and histopathology with more highly correlated survival outcomes than histopathologic grading alone","journal-title":"Cancer Cell"},{"issue":"7","key":"496_CR3","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1093\/neuonc\/now016","volume":"18","author":"J Wu","year":"2016","unstructured":"Wu J, Armstrong TS, Gilbert MR. Biology and management of ependymomas. Neuro-Oncology. 2016;18(7):902\u201313. doi: 10.1093\/neuonc\/now016 .","journal-title":"Neuro-Oncology"},{"issue":"5","key":"496_CR4","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1227\/00006123-199105000-00005","volume":"28","author":"EA Healey","year":"1991","unstructured":"Healey EA, Barnes PD, Kupsky WJ, Scott RM, Sallan SE, Black PM, et al. The prognostic significance of postoperative residual tumor in ependymoma. Neurosurgery. 1991;28(5):666\u201371. discussion 71-2","journal-title":"Neurosurgery"},{"issue":"Pt 5","key":"496_CR5","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1093\/brain\/awm046","volume":"130","author":"P Metellus","year":"2007","unstructured":"Metellus P, Barrie M, Figarella-Branger D, Chinot O, Giorgi R, Gouvernet J, et al. Multicentric French study on adult intracranial ependymomas: prognostic factors analysis and therapeutic considerations from a cohort of 152 patients. Brain. 2007;130(Pt 5):1338\u201349. doi: 10.1093\/brain\/awm046 .","journal-title":"Brain"},{"issue":"2","key":"496_CR6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00000421-200204000-00003","volume":"25","author":"AC Paulino","year":"2002","unstructured":"Paulino AC, Wen BC, Buatti JM, Hussey DH, Zhen WK, Mayr NA, et al. Intracranial ependymomas: an analysis of prognostic factors and patterns of failure. Am JClin Oncol. 2002;25(2):117\u201322.","journal-title":"Am JClin Oncol"},{"issue":"3","key":"496_CR7","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1093\/neuonc\/nou162","volume":"17","author":"E Vera-Bolanos","year":"2015","unstructured":"Vera-Bolanos E, Aldape K, Yuan Y, Wu J, Wani K, Necesito-Reyes MJ, et al. Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients. Neuro-Oncology. 2015;17(3):440\u20137. doi: 10.1093\/neuonc\/nou162 .","journal-title":"Neuro-Oncology"},{"issue":"3","key":"496_CR8","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/cncr.30355","volume":"123","author":"AA Acquaye","year":"2017","unstructured":"Acquaye AA, Vera E, Gilbert MR, Armstrong TS. Clinical presentation and outcomes for adult ependymoma patients. Cancer. 2017;123(3):494\u2013501. doi: 10.1002\/cncr.30355 .","journal-title":"Cancer"},{"issue":"2","key":"496_CR9","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s11060-014-1638-4","volume":"121","author":"T Walbert","year":"2015","unstructured":"Walbert T, Mendoza TR, Vera-Bolanos E, Acquaye A, Gilbert MR, Armstrong TS. Symptoms and socio-economic impact of ependymoma on adult patients: results of the adult ependymoma outcomes project 2. J Neuro-Oncol. 2015;121(2):341\u20138. doi: 10.1007\/s11060-014-1638-4 .","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"496_CR10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1092-9134(99)80004-5","volume":"3","author":"RA Prayson","year":"1999","unstructured":"Prayson RA. Clinicopathologic study of 61 patients with ependymoma including MIB-1 immunohistochemistry. Ann Diagn Pathol. 1999;3(1):11\u20138.","journal-title":"Ann Diagn Pathol"},{"issue":"3","key":"496_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s11060-007-9411-6","volume":"85","author":"EJ Rushing","year":"2007","unstructured":"Rushing EJ, Cooper PB, Quezado M, Begnami M, Crespo A, Smirniotopoulos JG, et al. Subependymoma revisited: clinicopathological evaluation of 83 cases. J Neuro-Oncol. 2007;85(3):297\u2013305. doi: 10.1007\/s11060-007-9411-6 .","journal-title":"J Neuro-Oncol"},{"issue":"4","key":"496_CR12","first-page":"304","volume":"10","author":"RA Prayson","year":"1997","unstructured":"Prayson RA. Myxopapillary ependymomas: a clinicopathologic study of 14 cases including MIB-1 and p53 immunoreactivity. Mod Pathol. 1997;10(4):304\u201310.","journal-title":"Mod Pathol"},{"key":"496_CR13","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Ellison DW, Figarella-Branger D, et al. WHO classification of tumours of the central nervous system. Revised 4th Ed. World Health Organization Classification of Tumours. Lyon: International Agency for Research on Cancer (IARC); 2016. The 2016 update of the WHO classification of tumours of the central nervous system incorporates many of the new genetic findings that define ependymomas.","DOI":"10.1007\/s00401-016-1545-1"},{"issue":"7489","key":"496_CR14","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nature13109","volume":"506","author":"M Parker","year":"2014","unstructured":"\u2022\u2022 Parker M, Mohankumar KM, Punchihewa C, Weinlich R, Dalton JD, Li Y, et al. C11orf95-RELA fusions drive oncogenic NF-kappaB signalling in ependymoma. Nature. 2014;506(7489):451\u20135. doi: 10.1038\/nature13109 . Basic science research identifying oncogenic fusion genes in supratentorial ependymoma","journal-title":"Nature"},{"key":"496_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1477-5751-10-7","volume":"10","author":"DW Ellison","year":"2011","unstructured":"Ellison DW, Kocak M, Figarella-Branger D, Felice G, Catherine G, Pietsch T, et al. Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts. J Negat Results Biomed. 2011;10:7. doi: 10.1186\/1477-5751-10-7 .","journal-title":"J Negat Results Biomed"},{"issue":"4","key":"496_CR16","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3171\/jns.2000.93.4.0605","volume":"93","author":"D Figarella-Branger","year":"2000","unstructured":"Figarella-Branger D, Civatte M, Bouvier-Labit C, Gouvernet J, Gambarelli D, Gentet JC, et al. Prognostic factors in intracranial ependymomas in children. J Neurosurg. 2000;93(4):605\u201313. doi: 10.3171\/jns.2000.93.4.0605 .","journal-title":"J Neurosurg"},{"issue":"5","key":"496_CR17","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1227\/01.neu.0000209928.04532.09","volume":"58","author":"BT Ragel","year":"2006","unstructured":"Ragel BT, Osborn AG, Whang K, Townsend JJ, Jensen RL, Couldwell WT. Subependymomas: an analysis of clinical and imaging features. Neurosurgery. 2006;58(5):881\u2013890; discussion -90. doi: 10.1227\/01.neu.0000209928.04532.09 .","journal-title":"Neurosurgery"},{"issue":"11","key":"496_CR18","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2176\/nmc.50.1020","volume":"50","author":"Y Akamatsu","year":"2010","unstructured":"Akamatsu Y, Utsunomiya A, Suzuki S, Endo T, Suzuki I, Nishimura S, et al. Subependymoma in the lateral ventricle manifesting as intraventricular hemorrhage. Neurologia Med Chir (Tokyo). 2010;50(11):1020\u20133.","journal-title":"Neurologia Med Chir (Tokyo)"},{"issue":"6","key":"496_CR19","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S1130-1473(10)70100-7","volume":"21","author":"R Carrasco","year":"2010","unstructured":"Carrasco R, Pascual JM, Navas M, Fraga J, Manzanares-Soler R, Sola RG. Spontaneous acute hemorrhage within a subependymoma of the lateral ventricle: successful emergent surgical removal through a frontal transcortical approach. Neurocirugia (Astur). 2010;21(6):478\u201383.","journal-title":"Neurocirugia (Astur)"},{"issue":"2","key":"496_CR20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00006123-199602000-00004","volume":"38","author":"GI Jallo","year":"1996","unstructured":"Jallo GI, Zagzag D, Epstein F. Intramedullary subependymoma of the spinal cord. Neurosurgery. 1996;38(2):251\u20137.","journal-title":"Neurosurgery"},{"issue":"5","key":"496_CR21","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3171\/jns.1978.49.5.0689","volume":"49","author":"BW Scheithauer","year":"1978","unstructured":"Scheithauer BW. Symptomatic subependymoma. Report of 21 cases with review of the literature. J Neurosurg. 1978;49(5):689\u201396. doi: 10.3171\/jns.1978.49.5.0689 .","journal-title":"J Neurosurg"},{"issue":"2","key":"496_CR22","first-page":"53","volume":"23","author":"AM Ralte","year":"2004","unstructured":"Ralte AM, Rao S, Sharma MC, Suri A, Gaikwad S, Sarkar C. Myxopapillary ependymoma of the temporal lobe\u2014report of a rare case of temporal lobe epilepsy. Clin Neuropathol. 2004;23(2):53\u20138.","journal-title":"Clin Neuropathol"},{"issue":"4","key":"496_CR23","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1227\/01.NEU.0000137278.84588.06","volume":"55","author":"N Tzerakis","year":"2004","unstructured":"Tzerakis N, Georgakoulias N, Kontogeorgos G, Mitsos A, Jenkins A, Orphanidis G. Intraparenchymal myxopapillary ependymoma: case report. Neurosurgery. 2004;55(4):981.","journal-title":"Neurosurgery"},{"issue":"5","key":"496_CR24","first-page":"1017","volume":"33","author":"H Sato","year":"1983","unstructured":"Sato H, Ohmura K, Mizushima M, Ito J, Kuyama H. Myxopapillary ependymoma of the lateral ventricle. A study on the mechanism of its stromal myxoid change. Acta Pathol Jpn. 1983;33(5):1017\u201325.","journal-title":"Acta Pathol Jpn"},{"issue":"1","key":"496_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10014-011-0059-8","volume":"29","author":"S Chakraborti","year":"2012","unstructured":"Chakraborti S, Govindan A, Alapatt JP, Radhakrishnan M, Santosh V. Primary myxopapillary ependymoma of the fourth ventricle with cartilaginous metaplasia: a case report and review of the literature. Brain Tumor Pathol. 2012;29(1):25\u201330. doi: 10.1007\/s10014-011-0059-8 .","journal-title":"Brain Tumor Pathol"},{"issue":"2","key":"496_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.clineuro.2004.12.010","volume":"108","author":"SC Lim","year":"2006","unstructured":"Lim SC, Jang SJ. Myxopapillary ependymoma of the fourth ventricle. Clin Neurol Neurosurg. 2006;108(2):211\u20134. doi: 10.1016\/j.clineuro.2004.12.010 .","journal-title":"Clin Neurol Neurosurg"},{"issue":"4","key":"496_CR27","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/1097-0142(19850815)56:4<883::AID-CNCR2820560431>3.0.CO;2-6","volume":"56","author":"PR Sonneland","year":"1985","unstructured":"Sonneland PR, Scheithauer BW, Onofrio BM. Myxopapillary ependymoma. A clinicopathologic and immunocytochemical study of 77 cases. Cancer. 1985;56(4):883\u201393.","journal-title":"Cancer"},{"issue":"4","key":"496_CR28","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.jaad.2009.11.027","volume":"65","author":"LM Burdick","year":"2011","unstructured":"Burdick LM, Bergfeld W, Somani N, Piliang M. Subcutaneous myxopapillary ependymal rest: a potential sign of spinal dysraphism. J Am Acad Dermatol. 2011;65(4):851\u20134. doi: 10.1016\/j.jaad.2009.11.027 .","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"496_CR29","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.ijrobp.2008.09.034","volume":"74","author":"A Pica","year":"2009","unstructured":"Pica A, Miller R, Villa S, Kadish SP, Anacak Y, Abusaris H, et al. The results of surgery, with or without radiotherapy, for primary spinal myxopapillary ependymoma: a retrospective study from the rare cancer network. Int J Radiat Oncol Biol Phys. 2009;74(4):1114\u201320. doi: 10.1016\/j.ijrobp.2008.09.034 .","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"496_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11060-006-9169-2","volume":"80","author":"S Akyurek","year":"2006","unstructured":"Akyurek S, Chang EL, Yu TK, Little D, Allen PK, McCutcheon I, et al. Spinal myxopapillary ependymoma outcomes in patients treated with surgery and radiotherapy at M.D. Anderson Cancer Center. J Neuro-Oncol. 2006;80(2):177\u201383. doi: 10.1007\/s11060-006-9169-2 .","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"496_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3171\/2010.9.spine09920","volume":"14","author":"ST Chao","year":"2011","unstructured":"Chao ST, Kobayashi T, Benzel E, Reddy CA, Stevens GH, Prayson RA, et al. The role of adjuvant radiation therapy in the treatment of spinal myxopapillary ependymomas. J Neurosurg Spine. 2011;14(1):59\u201364. doi: 10.3171\/2010.9.spine09920 .","journal-title":"J Neurosurg Spine"},{"issue":"3","key":"496_CR32","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.4081\/rt.2012.e42","volume":"4","author":"G Fegerl","year":"2012","unstructured":"Fegerl G, Marosi C. Stabilization of metastatic myxopapillary ependymoma with sorafenib. Rare Tumors. 2012;4(3):e42. doi: 10.4081\/rt.2012.e42 .","journal-title":"Rare Tumors"},{"issue":"5","key":"496_CR33","doi-asserted-by":"crossref","first-page":"494","DOI":"10.5761\/atcs.cr.10.01615","volume":"17","author":"S Maeda","year":"2011","unstructured":"Maeda S, Takahashi S, Koike K, Sato M. Primary ependymoma in the posterior mediastinum. Ann Thorac Cardiovasc Surg. 2011;17(5):494\u20137.","journal-title":"Ann Thorac Cardiovasc Surg"},{"issue":"5","key":"496_CR34","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/pgp.0000000000000156","volume":"34","author":"F Zhou","year":"2015","unstructured":"Zhou F, Song J, Mikolaenko I, Rosenblum M, Shukla PS. Pelvic ependymoma with clinical response to GnRH analog therapy: a case r eport with an overview of primary extraneural ependymomas. Int J Gynecol Pathol. 2015;34(5):450\u20138. doi: 10.1097\/pgp.0000000000000156 .","journal-title":"Int J Gynecol Pathol"},{"issue":"12","key":"496_CR35","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1016\/j.jocn.2014.05.011","volume":"21","author":"ET Sayegh","year":"2014","unstructured":"Sayegh ET, Aranda D, Kim JM, Oh T, Parsa AT, Oh MC. Prognosis by tumor location in adults with intracranial ependymomas. J Clin Neurosci. 2014;21(12):2096\u2013101. doi: 10.1016\/j.jocn.2014.05.011 .","journal-title":"J Clin Neurosci"},{"issue":"3","key":"496_CR36","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s11060-013-1237-9","volume":"115","author":"AA Aizer","year":"2013","unstructured":"Aizer AA, Ancukiewicz M, Nguyen PL, Macdonald SM, Yock TI, Tarbell NJ, et al. Natural history and role of radiation in patients with supratentorial and infratentorial WHO grade II ependymomas: results from a population-based study. J Neuro-Oncol. 2013;115(3):411\u20139. doi: 10.1007\/s11060-013-1237-9 .","journal-title":"J Neuro-Oncol"},{"issue":"2","key":"496_CR37","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ijrobp.2004.06.002","volume":"61","author":"DB Mansur","year":"2005","unstructured":"Mansur DB, Perry A, Rajaram V, Michalski JM, Park TS, Leonard JR, et al. Postoperative radiation therapy for grade II and III intracranial ependymoma. Int J Radiat Oncol Biol Phys. 2005;61(2):387\u201391. doi: 10.1016\/j.ijrobp.2004.06.002 .","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"496_CR38","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/neuonc\/nos286","volume":"15","author":"MC Oh","year":"2013","unstructured":"Oh MC, Ivan ME, Sun MZ, Kaur G, Safaee M, Kim JM, et al. Adjuvant radiotherapy delays recurrence following subtotal resection of spinal cord ependymomas. Neuro-Oncology. 2013;15(2):208\u201315. doi: 10.1093\/neuonc\/nos286 .","journal-title":"Neuro-Oncology"},{"issue":"1","key":"496_CR39","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/cncr.21110","volume":"104","author":"AA Brandes","year":"2005","unstructured":"Brandes AA, Cavallo G, Reni M, Tosoni A, Nicolardi L, Scopece L, et al. A multicenter retrospective study of chemotherapy for recurrent intracranial ependymal tumors in adults by the Gruppo Italiano Cooperativo di Neuro-Oncologia. Cancer. 2005;104(1):143\u20138. doi: 10.1002\/cncr.21110 .","journal-title":"Cancer"},{"issue":"20","key":"496_CR40","doi-asserted-by":"publisher","first-page":"4775","DOI":"10.1002\/cncr.24524","volume":"115","author":"MC Chamberlain","year":"2009","unstructured":"Chamberlain MC, Johnston SK. Temozolomide for recurrent intracranial supratentorial platinum-refractory ependymoma. Cancer. 2009;115(20):4775\u201382. doi: 10.1002\/cncr.24524 .","journal-title":"Cancer"},{"issue":"11","key":"496_CR41","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s00701-004-0374-5","volume":"146","author":"N Fakhrai","year":"2004","unstructured":"Fakhrai N, Neophytou P, Dieckmann K, Nemeth A, Prayer D, Hainfellner J, et al. Recurrent spinal ependymoma showing partial remission under Imatimib. Acta Neurochir. 2004;146(11):1255\u20138. doi: 10.1007\/s00701-004-0374-5 .","journal-title":"Acta Neurochir"},{"issue":"1","key":"496_CR42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1023\/A:1006394407245","volume":"45","author":"MK Gornet","year":"1999","unstructured":"Gornet MK, Buckner JC, Marks RS, Scheithauer BW, Erickson BJ. Chemotherapy for advanced CNS ependymoma. J Neuro-Oncol. 1999;45(1):61\u20137.","journal-title":"J Neuro-Oncol"},{"key":"496_CR43","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s12885-016-2323-0","volume":"16","author":"D Gramatzki","year":"2016","unstructured":"Gramatzki D, Roth P, Felsberg J, Hofer S, Rushing EJ, Hentschel B, et al. Chemotherapy for intracranial ependymoma in adults. BMC Cancer. 2016;16:287. doi: 10.1186\/s12885-016-2323-0 .","journal-title":"BMC Cancer"},{"issue":"suppl_5","key":"496_CR44","doi-asserted-by":"publisher","first-page":"v13","DOI":"10.1093\/neuonc\/nou237.23","volume":"16","author":"M Gilbert","year":"2014","unstructured":"Gilbert M, Yuan Y, Wani K, Wu J, Omuro A, Lieberman F, et al. AT-23A phase II study of lapatinib and dose-dense temozolomide (TMZ) for adults with recurrent ependymoma: a CERN clinical trial. Neuro-Oncology. 2014;16(suppl_5):v13. doi: 10.1093\/neuonc\/nou237.23 .","journal-title":"Neuro-Oncology"},{"issue":"7489","key":"496_CR45","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature13108","volume":"506","author":"SC Mack","year":"2014","unstructured":"\u2022\u2022 Mack SC, Witt H, Piro RM, Gu L, Zuyderduyn S, Stutz AM, et al. Epigenomic alterations define lethal CIMP-positive ependymomas of infancy. Nature. 2014;506(7489):445\u201350. doi: 10.1038\/nature13108 . Basic science research identifying epigenomic alterations in pediatric posterior fossa ependymomas as both causative and plausible therapeutic targets","journal-title":"Nature"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11864-017-0496-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-017-0496-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-017-0496-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T02:36:18Z","timestamp":1569983778000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11864-017-0496-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,10]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["496"],"URL":"https:\/\/doi.org\/10.1007\/s11864-017-0496-7","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,10]]},"article-number":"55"}}